A Study of CN1 in Combination With CN401 in Adult Patients With Relapsed/Refractory Lymphoid Malignancies
Clinical trial NCT04880564 · TERMINATED
Trial details
- NCT number
- NCT04880564
- Sponsor
- Curon Biopharmaceutical (Australia) Co Pty Ltd
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-28
- Primary completion
- 2022-08-29
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.